Inventor · disambiguated record
Clemens Kratochwil
Also filed as: KRATOCHWIL CLEMENS
3 granted patents·6 pending applications·20 citations·filing 2016–2024
65Inventor score
Files withUNIV HEIDELBERG4DEUTSCHES KREBSFORSCH1TELIX PHARMACEUTICALS INNOVATIONS PTY LTD1THE EUROPEAN ATOMIC ENERGY COMMUNITY EURATOM REPRESENTED BY THE EUROPEAN COMMISSION1UNIV HEIDELBERT1
Top patents by PatentIndex Score
9 records- 0194US10471160B2Labeled inhibitors of prostate specific membrane antigen (PSMA), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancerDEUTSCHES KREBSFORSCH·Filed 2018·Granted Nov 12, 2019·16 cites·28 claims
- 0279US2025127937A1Fap inhibitorUNIV HEIDELBERG·Filed 2024·Application pending·0 cites
- 0376US10980901B2Treatment of PMSA expressing cancersTHE EUROPEAN ATOMIC ENERGY COMMUNITY EURATOM REPRESENTED BY THE EUROPEAN COMMISSION·Filed 2016·Granted Apr 20, 2021·4 cites·13 claims
- 0474US2025057993A1Labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of psma-expressing cancersUNIV HEIDELBERG·Filed 2024·Application pending·0 cites
- 0571US2023112012A1Fap inhibitorUNIV HEIDELBERG·Filed 2022·Application pending·0 cites
- 0665US2021038749A1Fap inhibitorUNIV HEIDELBERG·Filed 2019·Application pending·0 cites
- 0761US2021393809A1Labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of psma-expressing cancersUNIV HEIDELBERT·Filed 2019·Application pending·0 cites
- 0845US2024238460A1Improved prostate-specific membrane antigen targeting radiopharmaceuticals and uses thereofTELIX PHARMACEUTICALS INNOVATIONS PTY LTD·Filed 2022·Application pending·0 cites
- 0943US12508271B2Prodrugs of 2-PMPA for healthy tissue protection during PSMA-targeted cancer imaging or radiotherapyUNIV JOHNS HOPKINS·Filed 2018·Granted Dec 30, 2025·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Clemens Kratochwil files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →